The C D l l /CD18 family of glycoproteins has been identified as a mediator of a number of adhesive interactions crucial to inflammatory responses. Using a monoclonal antibody (MoAb) against CD18 (TS1/18), the role of these molecules in polymorphonuclear neutrophil (PMNL) adhesion to cultured primary human umbilical vein endothelial cells (HUVEC) was examined under venous flow conditions. incubation of PMNL with TS1/18 (anti-CD18) did not inhibit PMNL adhesion to interleukin-1 (IL-1 )-treated HU-VEC at 2.0 dynes/cm2 (TSl/ll-treated 305 f 58 PMNL/ mm2 Y 334 f 63 PMNL/mm2 on control). Furthermore, incubation of HUVEC with R6.5.D6, an MoAb against intercellular adhesion molecule-1 (ICAM-1) did not significantly inhibit PMNL adhesion to IL-1-treated HUVEC at 2.0 dyneslcm' (P .3). In contrast to the lack of inhibition of adhesion under conditions of flow, incubation of PMNL with TS1/18 reduced PMNL adherence in static adhesion assays. PMNL migration beneath HUVEC monolayers has been shown to be stimulated by &hour IL-1 treatment. TS1/18 and R6.5.D6 significantly inhibited migration of PMNL beneath IL-1 -treated HUVEC monolayers under flow conditions by slightly more than 80% ( P < .005). In flow experiments with CD18-deficient PMNL, virtually no transendothelial migration was observed. The effect of FMLP (lo-* mol/L) on PMNL adhesion to untreated HUVEC 0 REACH A SITE of tissue injury or infection, T circulating polymorphonuclear neutrophils (PMNL) must first marginate to the blood vessel wall and form stable adhesions before migrating into the extravascular space. Blood flow-induced shear forces present in the circulation generate mechanical stresses on a PMNL forming adhesive bonds with the endothelium and, once the PMNL has adhered, act to detach it from the vessel wall. The magnitude of these disruptive forces appears to be an important factor in determining the outcome of leukocyte-adhesive interactions with the Additionally, the specific bonds believed to mediate cellkell adhesion can only form while the surfaces are in contact, which in the case of a circulating PMNL would be dependent on the local flow By incorporating flow into an adhesion assay, some of the physical constraints of force and contact time are simulated under which PMNL marginate and form attachments with the vessel wall. Furthermore, this initial adhesive interaction can be distinguished from PMNL spreading or transendotheLa1 migration.6.' '-I4
adhesion under conditions of flow, incubation of PMNL with TS1/18 reduced PMNL adherence in static adhesion assays. PMNL migration beneath HUVEC monolayers has been shown to be stimulated by &hour IL-1 treatment. TS1/18 and R6.5.D6 significantly inhibited migration of PMNL beneath IL-1 -treated HUVEC monolayers under flow conditions by slightly more than 80% ( P < .005). In flow experiments with CD18-deficient PMNL, virtually no transendothelial migration was observed. The effect of FMLP (lo-* mol/L) on PMNL adhesion to untreated HUVEC 0 REACH A SITE of tissue injury or infection, T circulating polymorphonuclear neutrophils (PMNL) must first marginate to the blood vessel wall and form stable adhesions before migrating into the extravascular space. Blood flow-induced shear forces present in the circulation generate mechanical stresses on a PMNL forming adhesive bonds with the endothelium and, once the PMNL has adhered, act to detach it from the vessel wall. The magnitude of these disruptive forces appears to be an important factor in determining the outcome of leukocyte-adhesive interactions with the Additionally, the specific bonds believed to mediate cellkell adhesion can only form while the surfaces are in contact, which in the case of a circulating PMNL would be dependent on the local flow By incorporating flow into an adhesion assay, some of the physical constraints of force and contact time are simulated under which PMNL marginate and form attachments with the vessel wall. Furthermore, this initial adhesive interaction can be distinguished from PMNL spreading or transendotheLa1 migration.6.' '- I4 Determination of the molecular basis of leukocyte adhesion deficiency disease has identified the leukocyte glycoprotein family CD11/18 as a mediator of a number of adhesive interactions crucial to inflammatory responses. This family of cell surface glycoproteins are found on lymphocytes, PMNL, and monocytes, and have been shown to be required for a number of adhesion-dependent functions of these The CDl1/18 family has been characterized structurally as three a//3 heterodimers with distinct a-subunits (CDl la,b,c) and identical @-subunits (CD18). Several laboratories have also shown that monoclonal antibodies (MoAbs) to the various subunits of CDl l /18, or to intercellular at wall shear stresses ranging from 0.25 to 2.0 dynes/cm2 was also investigated. FMLP had little effect on PMNL adherence at shear stresses above 0.5 dynes/cm2 (P > .45).
In response to FMLP exposure at lower wall shear stresses, PMNL adherence to untreated HUVEC increased 6.9-fold at 0.5 dynes/cm2 (P < .001). At 0.25 dynes/cm2. FMLP stimulation increased PMNL adherence to untreated HUVEC 6.5-fold compared with controls ( P < .005), and FMLP failed to make CD18-deficient PMNL more adherent. In experiments with PMNL pretreated with TS1/18 (antiCDl8). there was a 67% inhibition of FMLP-stimulated adhesion at 0.5 dynes/cm2 (P < .025). The upper threshold of CD18-mediated PMNL adhesion appears to be between 0.5 and 1 .O dyne/cm2. Above these wall shear stresses, the initial attachment of PMNL to cultured endothelium was mediated almost exclusively by CD18-independent mechanisms. By simulating some of the flow parameters in the microcirculation with well-characterized shear forces, PMNL adhesion by CD1 8-independent and dependent mechanisms can be differentiated. These data also indicate that CD18 is an important mediator of transendothelial migration by PMNL, which have attached to the endothelium by a CD1 8-independent mechanism. 0 1990 by The American Society of Hematology.
adherence molecule-1 (ICAM-l), a ligand to C D l l a expressed on many tissue cells, can inhibit adherence and adherence-dependent functions of normal PMNL in a manner that closely mimics patient PMNL.12*18-20 It has also been shown that MoAbs to the CD11/18 family significantly, but not completely, inhibit PMNL adhesion to endothelial cell monolayers, particularly after interleukin-1 (IL-l), lipopolysaccharide (LPS), or thrombin treatment of the monolayers.'2.2''22 This component of adhesion that is not blocked by MoAbs to CD18 on normal PMNL and also exhibited by patient PMNL suggests that other mechanisms of PMNL adhesion exist. One such mechanism has recently been identified by Bevilacqua et a123 and involves a molecule distinct from ICAM-1 called endothelial-leukocyte adhesion molecule-1 (ELAM-1).
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Using MoAbs against CD18 and ICAM-1, we examined the role of these molecules in PMNL adhesion to cultured human endothelial cells (HUVEC) in the presence of shear forces similar to those found in the venous circulation. Agonists that upregulate CD18 on the neutrophil (FMLP), and ICAM-1 on the endothelial cell (IL-I) were used to evaluate the relative contributions of these glycoproteins in PMNL attachment to HUVEC. Under flow, the adhesive interaction can be separated into CD18/ICAM-l-dependent and independent components. PMNL adherence above wall shear stresses of 0.5 dyne/cm2 and the formation of PMNL rolling attachments appear to be principally CDI 8/ ICAM-I-independent adhesive interactions, while attachment to noncytokine-stimulated HUVEC can be mediated by CD18 at shear stresses of 0.5 dynes/cm2 and below. We also present data indicating that CDl8 and ICAM-1 are important mediators of transendothelial migration by PMNL, which have attached to the endothelium by CD18-independent mechanisms, and that suggests a regulatory role for ICAM-1 in this phenomenon.
MATERIALS AND METHODS
HUVECs were harvested from 5 to 10 cords using collagenase digestion.24 Pooled cells were resuspended in M199 (GIBCO Laboratories, New York, NY) supplemented with 20% heat-inactivated fetal bovine serum (HyClone Laboratories Inc, Logan, UT), penicillin, streptomycin, and neomycin (2% by volume of lOOX stock; GIBCO), and glutamine (1% by volume of lOOX stock; GIBCO). Monolayers were prepared by plating the HUVEC suspension onto glass slides (38 x 75 mm; Fischer Scientific Co, Springfield, NJ) that had been treated with 0.5 NaOH to give them a negative charge. Primary HUVEC cultures were used in experiments within 2 days of reaching confluence.
Venous blood from normal donors was drawn into citrate anticoagulated dextran sedimentation fluid. After sedimentation and centrifugation over Ficoll-Hypaque, the erythrocytes were hypotonically lysed. The final resuspension was in cold M199, pH adjusted to 7.4, at which point the number of PMNL was measured using a Coulter Counter (Model ZBI, Coulter Electronics Inc, Hialeah, FL) interfaced to a Coulter Channelyzer (Coulter Electronics) to determine the appropriate dilution ratios for the flow experiments. PMNL from two patients with a severe form of CD18 deficiency were isolated using the same procedure.2s Trypan blue exclusion showed greater than 97% viability on a consistent basis.
To simulate the fluid shear stresses present in the microvasculature, a parallel plate geometry was used for our flow ~h a m b e r .~~'~*~ The chamber consisted of a glass slide seeded with a confluent monolayer of endothelial cells (HUVEC) that was attached to a polycarbonate base. Once assembled, these two flat surfaces were held approximately 250 pm apart by a Silastic rubber gasket (Dow Corning, Midland, MI). The channel Reynolds number was less than 4 under the flow conditions used, indicating the flow was not turbulent. The wall shear stress was calculated using the momentum balance for a Newtonian fluid. The viscosity of water at 37OC was used as an approximation of the viscosity of the M199 buffer (0.007 poise). As described in the following equation, the wall shear stress the HUVEC monolayer experiences is equal to: T = 3jtQ/2ba2, where T = wall shear stress, jt = coefficient of viscosity (0.7cP), Q = volumetric flow rate (cm'/s), a = half channel height (127 x cm), and b = channel width (1.4 cm). The wall shear rate is given by TIP.
Endothelialcellcultures.
Isolation of human PMNL.
Experimental apparatus.
A model 935 Harvard Apparatus syringe pump (South Natick, MA) was used for flow control. Experiments were conducted at shear rates ranging from 35 s ' to 560 s-'. These shear rates are believed to be characteristic of the fluid shear stresses that a marginating leukocyte must resist to form a stable adhesion with the vessel wall. The shear stresses corresponding to these shear rates for tissue culture medium at 37OC range from 0.25 to 4.0 dynes/cm2 and are directly proportional to the flow rate.
PMNL interactions with HUVEC were directly visualized using phase-contrast optics (Nikon Diaphot-TMD, Garden City, NY). Experiments were videotaped (RCA model TC3800, Lancaster, PA) using a silicon-intensified target camera (SIT, model C1012, Hamamatsu Inc, Waltham, MA). The number of PMNL/mm* attached to the HUVEC monolayer were counted after 10 minutes of flow. An adherent PMNL is defined to include PMNL that form stationary adhesions, PMNL that have migrated beneath the HUVEC monolayer, and also PMNL that have formed rolling attachments with the HUVEC m~nolayer.~ At a wall shear rate of 250 s-' (approximately 2 dynes/cm' wall shear stress), a fluid element 4 pm from the endothelial cell monolayer (approximately 1 PMNL radius) would be moving at almost 1,000 pm/s. A PMNL rolling at 40 pm/s would be rolling at a velocity 25 times less than this, indicating that there is an adhesive interaction occurring with the HUVEC monolayer. Image frames from videotaped experiments recorded were digitized (Perceptive Systems Inc, Houston, TX) using a low pass filter so fast-moving objects would not be counted in the adherent population. The adherent population does not include any PMNL rolling faster than 50 pm/s. To measure rolling velocities, images from the videotape of an experiment were digitized 2 seconds apart, and the distance the PMNL had moved during the interval was computed in pixels, which were subsequently converted to velocities in jtm/s. Several pairs of image frames were analyzed in an experiment and their individual average rolling velocities were combined to produce a representative value for that particular experiment. At least 250 PMNL were measured in any experiment.
To study PMNL adhesion under static conditions, a protocol to minimize the effect of shear forces in washing the monolayer was used." The PMNL suspension was perfused through the flow chamber for a short period of time, then flow was stopped to allow the PMNL to settle onto the monolayer. After 5 minutes, the flow chamber was inverted on the stage of the microscope for another 5 minutes to allow the unattached PMNL to sediment to the other side of the chamber. After this the chamber was reinverted, the monolayer quickly scanned, and the microscope fields of view recorded on videotape. Ten fields of view were normally recorded and the results are reported as percent inhibition relative to control values.
Quantitation of PMNL migration beneath the H W E C monolayer. During flow experiments, PMNL were observed migrating beneath the HUVEC monolayer.6,' 1-14.28,29 Normally in these experiments the attached PMNL were rounded up and appeared as bright white dots under phase-contrast. Once the PMNL have migrated they became spread and phase-dark!." Continuous monitoring of the field of view permitted the identification of PMNL, which had changed from phase-bright to phase-dark.
Pretreatment of HUVEC with IL-I. HUVEC monolayers were pretreated with IL-1 for 4 hours before the e~periment.",~' Concentrations of IL-1 were used that would give a maximum level of EC adhesiveness (0.5 to 2 U/mL). Human monocyte-derived IL-1 (Genzyme Inc, Boston, MA) was added directly to the media in which the HUVEC were cultured. The final concentration of IL-1 in the media was 2 U/mL for most experiments. To begin an experiment, the slide covered with the monolayer of HUVEC was fitted onto the flow chamber and rinsed with serum-free M199 at 37OC for 20 to 30 minutes at wall shear stress of 1.0 dyne/cm2. The cold
Static adhesion experiments.
PMNL suspension was diluted to a concentration of 1,000 PMNL/ pL with warmed MI99 and incubated at 37OC for 30 minutes before the experiment. The PMNL suspension, connecting tubing, and microscope with flow chamber were all maintained at 37OC by an air-curtain incubator (Laboratory Products, Boston, MA).
HUVEC monolayers were pretreated with LPS for 4 hours before the experiment."." LPS (Escherichia coli 026:86; Sigma Chemical Co, St Louis. MO) was dissolved in sterile saline (0.9% wt/vol) and added directly to the tissue culture medium in which the HUVEC were cultured. The final concentration of LPS in the media was 1 pg/mL. The rest of the experimental procedure was identical to that of the IL-l experiments.
FMLP was diluted to IO ' mol/L in saline before addition to the PMNL suspension. Incubation times ranged up to 15 minutes. In most experiments, the FMLP was added 4 minutes after the start of flow. This procedure allowed an internal control of baseline adhesion to be established that could be compared with the level of FMLP-stimulated PMNL adhesion on the same monolayer. After the baseline adherence was established under the appropriate flow conditions, FMLP (IO ' mol/L) was injected into the PMNL suspension being warmed in the water bath at 37°C.
resulting in a final concentration of IO-" mol/L. The flow rate was raised for 40 seconds to bring the FMLP solution into the flow chamber, then reduced to the original flow rate. After this procedure, PMNL could be observed interacting with the HUVEC monolayer within I minute of their initial exposure to FMLP. This procedure for exposing PMNL to FMLP and introducing the FMLP suspension into the flow chamber was used to measure the erect of FMLP on PMNL adhesion to untreated HUVEC and also to IL-I-treated HUVEC. Inhibition was based on the percent blocking of the FMLP-stimulated component of PMNL adhesion after the non-FMLP component of adherence was subtracted out.
MoAbs directed against the CD18 family included dilutions of ascites fluid as well as purified preparations of TS1/18 (IgGI).'* The MoAb against ICAM-I was R6.5.D6 (IgG2a).I2 The concentrations used are indicated in the specific experiments and were approximately IO times higher than the concentration required to completely saturate the binding sites. Saturation of CD18 binding sites on FMLP-stimulated PMNL was confirmed using flow cytometry. An MoAb directed against the major histocompatibility complex (MHC) class I surface antigen (W6/32, IgG2a) served as a control in selected experiments. PMNL, and HUVEC monolayers in ssme cases, were incubated with the indicated MoAbs for at least I5 minutes at 37OC before the experiment.
Results are presented as means * the standard error of the mean (SEM), and n equals the number of experiments. Statistical assessments were made using the two-tailed Student's t-test for paired data since each experiment was performed on HUVEC monolayers from the same pooled seeding, and PMNL used in an experiment were from the same donor. P c .05 was judged to be statistically significant.
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RESULTS
Eflect of shear stress on PMNL adhesion to IL-1 and LPS-Ireated HUVEC monolayers. In paired experiments at 2.0 dynes/cm2 wall shear stress, 371 t 25.8 PMNL/mm2 (mean 2 SEM) adhered to IL-I-treated (2 U/mL) HUVEC, and 28 t 2.9 PMNL/mm2 adhered to control HUVEC after I O minutes of flow (n = 5. P < .01, Student's t-test, Fig I ) . At 3.0 dynes/cm2 wall shear stress, 10.2 t 3.8 PMNL/mm2 adhered to IL-I-treated HUVEC and 6.8 t 3.5 PMNL/mm2 adhered to control HUVEC. On LPStreated HUVEC, 308 t 49 PMNL/mm2 adhered at a wall shear stress of 2.0 dynes/cm2 and 31 2 15 PMNL/mm2 adhered to the control HUVEC ( P < .01, n = 4). Raising the wall shear stress to 3.0 dynes/cm' resulted in a significant drop in adhesion, with 18.3 t 8.4 PMNL/mm2 adhering to LPS-treated HUVEC and 5.3 2 1.8 PMNL/mm2 to control HUVEC (Fig I ) . PMNL adherence to both LPS-treated and IL-I-treated HUVEC decreased significantly at 3.0 dynes/ cm2 compared with adherence at 2.0 dynes/cm2 ( P < ,005). In both cases the endothelial cells were stimulated to what appears to be their maximal adhesiveness in response to these agonists as demonstrated in static adhesion assay^.'^.^'.'^.^'.^^ Flow experiments on HUVEC monolayers that had been exposed to IL-l (2 U/mL) for 24 hours showed only basal levels of adhesion (n = 2, average = 14 PMNL/mm2).
As mentioned in the Materials and Methods section, the total adherent PMNL counts included PMNL with rolling attachments, PMNL stationary on the apical surface of the HUVEC monolayer, and PMNL that had migrated beneath the monolayer. On IL-l and LPS-treated monolayers, the range of behavior of adherent PMNL would include stopping, rolling downstream, and occasional detachment. There was a constant exchange between the population of adherent PMNL on the apical surface of the HUVEC monolayer and PMNL in suspension, with new attachments eventually balanced by detachments once the number of adherent PMNL reached a steady state, usually within 4 minutes of starting flow of the PMNL suspension a t 2.0 dynes/cm2. The downstream rolling of PMNL attached to the IL-I-treated HUVEC monolayer ranged from zero to 40 pm/s. with an average of 8.9 t 0.7 pm/s (n = 1 I). The rolling velocities of PMNL attached to unstimulated HUVEC controls were significantly lower, with an average of 0.95 f 0.5 pm/s (n = 6, P < .005). The percent of PMNL attached to IL-I-treated HUVEC that were rolling a t velocities greater than 0 pm/s was 71% f 3.7% (n = 11). The percent of attached PMNL rolling on untreated controls was also significantly lower, with an average of 46% f 6.0% rolling on untreated monolayers (n = 6, P c .005).
Eflect of anti-CDl8 and anti-ICAM-1 MoAbs on PMNL adhesion to IL-I-treated HUVEC at a wall shear stress of 2.0 dyneslcm'. Incubation of PMNL with TS1/18 (40 pg/mL) did not inhibit PMNL adhesion to IL-I-treated HUVEC a t 2.0 dynes/cm2 (Fig 2) . On IL-I-treated HU-VEC, 305 +. 58 PMNL/mmZ adhered after treatment with TS1/18 and 334 63 PMNL/mm2 adhered in runs using untreated neutrophils (n = 7, P = .4). The anti-ICAM-l MoAb R6.5.D6 showed no inhibition of PMNL adhesion to IL-I-treated HUVEC a t 2.0 dynes/cm2 wall shear stress as well (Fig 3) . On IL-I-treated HUVEC monolayers exposed to saturating concentrations of R6.5.D6 in buffer" (30 pg/mL, IO minutes under flow and in PMNL suspension), 246 52 PMNLlmm'adhered while287 * 53 PMNL/mmz adhered to IL-I-treated control monolayers (n = 5, P > .3).
We performed an experiment using PMNL isolated from a patient with CDI 8-deficiency and compared the number of PMNL adhering to IL-I-treated HUVEC with those from a normal donor (Fig 4) . On IL-I-treated HUVEC, 323 CDI8-deficient PMNL/mm2 adhered and 309 normal PMNL/mmZ adhered a t 2.0 dynes/cm2. On untreated HU-VEC monolayers, I O CDI 8-deficient PMNL/mm' and 19 normal PMNL/mmZ adhered under the same flow conditions.
Effect of TS1118 (anti-CD18) on PMNL adherence t o IL-1 -treated HUVEC under flow conditions. Monolayers of confluent HUVEC were pretreated with IL-1 (2 UlmL) for 4 hours before an experiment. PMNL were pretreated for 15 minutes at 37°C with dilutions of ascites fluid containing TS1/18 or purified antibody at concentrations 8 t o 10 times what was found t o be effective in inhibiting PMNL adherence to HUVEC in static adhesion assays. TS1/18 was present in the PMNL suspension and was continuously present during the experiment. The flow rate was 2.0 dynes/cm2 wall shear stress. Untreated PMNL were used as controls for the effect of TS1/18 on PMNL adhesion to IL-ltreated monolayers. The effect of 11-1 -stimulation was controlled for in antibody-blocking experiments with untreated HUVEC monolayers. m~n o l a y e r . '~"~ During flow experiments some adherent PMNL migrated beneath the IL-I-treated EC monolayer. As has been described by others, PMNL that migrated changed from phase-bright to phase-dark and became highly spread (Fig 5 ) . Migration of PMNL attaching a t shear stresses of 2.0 dynes/cm2 ranged in separate experiments from 14 to 222 PMNL/mm2, and at 0.5 dynes/cm2 ranged from 76 to 248 PMNL/mm2. As shown in Table 1 , in paired experiments T S l / I8 significantly inhibited migration in experiments at 2.0 and 0.5 dynes/cm2 (P < .005). CD18-deficient PMNL failed to migrate significantly after attaching to HUVEC monolayers at either shear stress. The anti-ICAM-1 MoAb, R6.5.D6, also significantly inhibited migration in experiments a t 2.0 dynes/cm2 (P < .Ol), but was not tested a t 0.5 dynes/cm2. An isotype-matched control MoAb, W6/32 (40 pg/mL), was not inhibitory (n = 2).
Efect of FMLP and CD18 on P M N L adhesion to untreated HUVEC. Figure 6 shows the effect of brief (under 5 minutes) exposure of PMNL to FMLP a t a concentration of lo-* mol/L on PMNL adhesion to untreated HUVEC at wall shear stresses ranging from 0.25 to 2.0 dynes/cm2. FMLP pretreatment of PMNL had little effect on PMNL adherence a t shear stresses above 0.5 dynes/cm2. At 2.0 dynes/cm2 there was no difference between FMLP-treated PMNL adherence and untreated controls (P = .5, n = 3). At 1 .O dyne/cm2, FMLP-treated PMNL adherence was also not statistically different from controls (P > .45, n = 3). At 0.5 dynes/cm2 and below, a significant increase in PMNL adherence was observed after exposure of PMNL to FMLP (Fig 6) . Increases in adhesion averaged 6.9-fold a t 0.5 dynes/cm2(FMLP-treated 332 k 71 PMNL/mm2v48 +. 14 PMNL/mm2 on controls, P < .005, n = 5). At 0.25 dynes/ cm2, increases in PMNL adherence averaged 6.5-fold in response to FMLP stimulation (FMLP-treated 856 k 39 PMNL/mm2 v 132 k 23 PMNL/mm2 on controls, P < .005, n = 4).
In an effort to determine if CD18 is involved in the FMLP-stimulated adhesion that occurs a t lower wall shear stresses, PMNL in paired experiments were exposed to TS1/18 or a control MoAb, W6/32, a t concentrations sufficient to saturate all binding sites. Without chemotactic stimulation, adherence of these PMNL to untreated HU-VEC at 0.5 dynes/cm2 was not significantly different (in the presence of W6/32, 102 k 57 PMNL/mm2; of TS1/18. 44 k 8 PMNL/mm2). However, as seen in Fig 7, PMNL stimulated with FMLP in the presence of TS1/18 were significantly less adherent to untreated HUVEC a t 0.5 dynes/cm2 than PMNL stimulated in the presence of W6/32 (with TS1/18, 178 2 55 PMNL/mm*; with W6/32, seconds to bring the FMLP-stimulated PMNL into the flow chamber, and then flow was dropped back to the initial wall shear stress. Adherent PMNL counts were made 8 minutes after the addition of FMLP and compared with the internal control established by the level of PMNL adherence before FMLP was added. Effect of FMLP stimulation on PMNL adherence was further controlled for by performing paired experiments without FMLP stimulation using HUVEC from same pooled seeding and PMNL from the same isolation procedure. Error bars represent the SEM. , and the addition of TS1/18 did not alter adhesion (291 f 15 PMNL/mm2, n = 2). Also consistent with the results using untreated HUVEC was the finding that FMLP stimulation significantly increased adhesion to IL-1-treated HUVEC at 0.5 dyneslcm' (Table 2) . However, the effect on adhesion of adding TS1/18 was different with IL-1-treated HUVEC than with untreated HUVEC. While the addition of TSl / 18 significantly inhibited the transendothelial migration induced by IL-1 simulation, a result consistent with previous experiments (Table l) , it did not reduce the enhanced adhesion to the apical surface of the endothelial monolayer induced by FMLP (Table 2) . Rolling velocities of adherent PMNL at wall shear stress of 0.5 dyneslcm2. At a wall shear stress of 0.5 dynes/", PMNL were observed to attach and form rolling adhesions on IL-1-treated HUVEC monolayers. An average of 40 f 5.2% of the adherent PMNL formed rolling adhesions. In contrast to the results at a wall shear stress of 2.0 dynes/cm2, the average PMNL rolling velocity was 2.3 f 0.22 pm/s, with values for individual cells ranging from 0 to 30 pm/s (n = 5). With TS1/18 pretreatment, the average PMNL rolling velocity on IL-1-treated HUVEC was 2.24 + 0.3 pm/s (n = 3) and was not significantly different from untreated PMNL attached to IL-1-treated monolayers (P > .4). Rolling velocity averages only include PMNL on the apical surface of the monolayer and do not include PMNL that have migrated beneath it. Were these nonrolling cells included, there would be a small but significant decrease in the average velocity relative to that of TS1/ 18-treated PMNL. In an experiment with CD18-deficient PMNL, the average rolling velocity was 4.6 0.5 pm/s at 0.5 dynes/cm2.
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As shown in Fig 9, FMLP exposure reduced the rolling velocity of normal PMNL attached IL-1-treated HUVEC monolayers from an average of 2.3 k 0.22 to 0.57 k 0.16 pm/s (P < .025, n = 3), and as previously noted, increased PMNL adherence (Table 2) pretreated with IL-1 as described previously. PMNL in some cases were pretreated with TS1/18 for 1 5 minutes at 37°C before the start of an experiment. Reported rolling velocities represent the average of all adherent PMNL including stationary ones in the field of view. Velocities were computed by comparing two digitized frames of videotape 2.0 seconds apart and measuring the distance all the adherent PMNL had moved. Several pairs of frames a minute apart were analyzed in this manner and averaged (each pair of videotape images involved measuring a minimum of 85 PMNLI. This determination was then averaged with the determinations from t w o other independent experiments on different HU-VEC monolayers t o produce the reported averages and SEM.
0.50 * 0.14 r m / s and were not significantly different from rolling velocities of FMLP-treated PMNL adherent to IL-1-treated monolayers (P .4, n = 3). In addition to reducing the rolling velocity, FMLP induced a marked shape change in PMNL adherent to both IL-1-treated and untreated HUVEC monolayers. The phase-bright cells (ie, those on the apical surface of the monolayer) were ruffled, bipolar, and flattened in appearance. Within 4 minutes of infusing FMLP into the flow system, PMNL rolling velocities dropped to the level observed for FMLP-stimulated PMNL attached to untreated HUVEC. In response to FMLP, many adherent PMNL were observed to change from a rounded morphology to a highly flattened one with many pseudopods extended.
Preceding the morphologic changes, many adherent PMNL over the period of several seconds slowed down and stopped rolling, which is reflected in the drop in the percent rolling from 40% k 5.2% to 20% k 1.2% in the presence of FMLP (P < .25).
DISCUSSION
The margination and attachment of leukocytes to the vessel wall in vivo takes place in the presence of widely varying levels of shear forces induced by the flow of blood and the local vessel size and geometry. Flow conditions a t physiologic levels have a significant effect on contact times between PMNL and endothelial cells, and perhaps more importantly, introduce forces on cell membranes that could mechanically hinder the formation of adhesive bonds. In a model vessel system with well-characterized fluid mechanics, some aspects of the forces that exist in the vasculature and that act on circulating blood cells can be stimulated. A parallel plate chamber produces a relatively simple shearing flow in a gap many times the diameter of a PMNL, therefore minimizing any interactions except those with the monolayer of endothelial cells. At the low Reynolds number flow rates used in these experiments, PMNL adherent to the monolayer experience approximately the same shear forces, so adherence was correlated directly with wall shear stress.
Under flow conditions, PMNL adhesion to HUVEC was observed to be very sensitive to the wall shear stress, and consequently the level of shear force acting on an adherent cell. PMNL attachment to IL-1-treated, LPS-treated, and untreated HUVEC occurred only after fluid shear forces had dropped below a threshold level that corresponds approximately to a wall shear stress of 3 dynes/cm2. Once below this threshold, the effect of cytokine-stimulation on PMNL adherence to HUVEC became significant relative to untreated controls, as has been observed in static system^.^'.^^.^^ The upper range of flow rates a t which PMNL were able to form attachments to the IL-1-and LPS-treated HUVEC was within the range of wall shear stresses estimated to be found in the venules (1 to 10 IL-1-and LPS-treatment of HUVEC have both been shown in static assay systems to increase PMNL adherence. This increase is due in part to the expression on the endothelial cell surface of a t least two distinct adhesive molecules, ICAM-1 ",I4 and ELAM-1 . 23 It has been fairly well-established that adhesion to endothelial cells mediated by the CD18 family of glycoproteins present on the PMNL surface requires ICAM-1 as a ligand, and that ELAM-1-mediated adherence appears to be independent of CD18 and ICAM-1 . 32 In an effort to determine the relative contribution of ICAM-1 to PMNL adherence to endothelial cells under flow conditions, MoAbs that have been shown to inhibit PMNL adherence to HUVEC (TS1/18 and R6.5.D6) were used to block this adherence mechanism. In addition, PMNL from a patient previously shown to be deficient in CD18 were used in selected flow experiment^.^^ At a wall shear stress of 2 dynes/cm*, TS1/18 (anti-CD18) and R6.5.D6 (anti-ICAM-1) did not inhibit PMNL adhesion to either IL-1-treated or untreated endothelial cells. The concentrations of these MoAbs used were in excess of those previously shown to be effective in static experiments and were continuously present during the flow experiments. FMLP treatment of PMNL, which has been shown to upregulate CD18 expression," did not increase PMNL adhesion to IL-1-treated endothelial cells a t this shear stress either. Furthermore, CD18-deficient PMNL attached to the IL-1 stimulated HUVEC to the same extent as cells from normal adults. This is in marked contrast to the behavior of PMNL from these patients compared with normal PMNL in the absence of shear stress.I2 In additional experiments with HUVEC monolayers that had been treated with IL-1 for 24 hours, normal PMNL exhibited no greater adherence than to unstimulated monolayers. While PMNL adherence to IL-1-or LPS-treated HUVEC in static systems reaches a peak in approximately 4 hours followed by a decline in adhesiveness, ICAM-1 expression remains high.37 These data imply that CD18 and ICAM-1 are not the principle mediators of PMNL margination and initial attachment to endothelium in a flow system that generates a wall shear stress of 2 dynes/cm2. This adhesive interaction apparently requires CD18-independent molecular mechanisms. These observations do not exclude contributions to the avidity of adhesion by CD18 once the PMNL has formed its initial attachment to the endothelium.
To control for artifacts in our procedures, several staticincubation experiments were performed using the flow apparatus by simply stopping flow. Significant inhibition of PMNL adhesion to IL-1-treated HUVEC by TS1/18 was observed, as well as a CDl8-independent component of adhesion similar to published results of other lab~ratories.'~~'~,'~,~' It is probable that the CD18-independent component of PMNL adhesion to IL-1-treated endothelial cells is what is observed a t 2 dynes/cm2. In support of the possible physiologic relevance of these observations, Arfors et al,38 observing the behavior of rabbit neutrophils in vivo, found that MoAb 60.3 (anti-CD18) markedly inhibited PMNL infiltration into inflammatory sites, but failed to inhibit leukocyte margination as evidenced by the number of leukocytes rolling along the vessel walls.
Under static conditions, PMNL not only adhere in greatly increased numbers to 4-hour IL-1-stimulated HUVEC, but they can rapidly migrate through the monolayer to a position beneath the endothelial cell^.'^^'^ This behavior is almost completely blocked by MoAbs to CD18 and ICAM-1, and fails to occur with CD18-deficient PMNL in static adhesion assays. During the course of flow experiments it was observed that PMNL, after adhering at 2 dynes/cm2, frequently migrated beneath the IL-1-stimulated HUVEC monolayer. In contrast to the apparent lack of involvement of CD18 in PMNL attachment to the HUVEC monolayer at 2 dynes/ cm', the anti-CD18 and anti-ICAM-1 MoAbs both inhibited transendothelial migration by slightly over 80%. On untreated HUVEC monolayers, which normally have low levels of ICAM-1 expression, very little migration was observed. These observations suggest that CD18 and its complementary ligand ICAM-1 are important mediators of transendothelial migration by PMNL, even for those which have attached to the endothelium by a CDl8-independent mechanism, and suggest a regulatory role for ICAM-1 in this phenomenon.
Activation of PMNL with chemotactic factors such as FMLP, C5a, and LTB, significantly increases their adherence to untreated HUVEC monolayers in the absence of shear ~t r e~~e~. '~,~~*~~-~~ This increase in adherence can be almost completely eliminated by anti-CD18 and anti-ICAM-1 MoAbs and fails to occur with CD18-deficient PMNL. The concentration of FMLP used mol/L) in these flow experiments has been shown to increase PMNL adherence to unstimulated HUVEC monolayers in nonflow adhesion assays and produce virtually complete expression of CD18 on the PMNL surface."*l6 However, it did not significantly increase PMNL adherence to unstimulated HUVEC at wall shear stresses above 0.5 dynes/cm2, consistent with the results of Worthen et a1.6 At 0.5 dynes/cm2, TS1/18 inhibited the FMLP-stimulated increase by 67%, and FMLP failed to make CD18-deficient PMNL more adherent at 0.25 dynes/cm' wall shear stress. Stimulation of PMNL with FMLP, in the presence or absence of the control binding antibody W6/32, was always observed to increase adherence of PMNL to untreated HUVEC monolayers at wall shear stresses of 0.5 dynes/cm' and under. The experiment with CDl 8-deficient PMNL further demonstrates that the principle mechanism of FMLP-stimulated adherence at lower wall shear stresses is dependent on CDl8.
A comparison of the effects of FMLP-stimulation on PMNL adhesion to unstimulated HUVEC at different wall shear stresses suggests that the upper threshold of CD18-mediated PMNL adhesion is between 0.5 and 2.0 dynes/cm2. Presumably, the number and/or strength of bonds the CD18 heterodimers form with the endothelial cell at wall shear stresses above 0.5 dynes/cm2 is inadequate to maintain a stable adhesion. The level of shear forces at which an activated PMNL can adhere without concurrent endothelial cell expression of additional adhesive ligands for non-CD18 receptors would probably be found only in very low flow regions of the vasculature (eg, the pulmonary bed46) or in regions of near stasis conditions such as might be found during phases of acute inflammation, as Worthen et a16 have proposed.
When FMLP-stimulated PMNL were perfused over IL-1-treated HUVEC monolayers at 0.5 dynes/cmz, adherence compared with unstimulated controls was increased. At this wall shear stress, the shear forces are low enough that both CD 18-independent and CDl8-dependent mechanisms likely mediate adhesion. However, despite the presence of saturating concentrations of TS1/ 18 throughout the experiment, adhesion of FMLP-stimulated PMNL to the apical surface of IL-l-stimulated monolayers was not different than PMNL with antibody. This suggests that either a CD18-independent adhesive mechanism is activated by the appropriate stimulation of both endothelial cells and PMNL, or that the MoAb is ineffective in this setting. Recently published experiments'2s47 performed under static conditions clearly demonstrated that chemotactic stimulation of CDl 8-deficient neutrophils failed to increase their adhesion to untreated HUVEC monolayers, monolayers stimulated for 24 hours with IL-1 (ie, a condition that results in predominately ICAM-1-CD18-dependent adhesion), or monolayers stimulated for 4 hours with IL-1 as in the current study (ie, a condition that promotes both CD 18-dependent and -independent adhesion). These observations argue against chemotactic activation of a CD18-independent mechanism. Because transendothelial migration was markedly reduced by TS1/18 both with and without chemotactic stimulation (Table 2) , it is unlikely that newly upregulated CD18 was not accessible for antibody binding. The most likely explanation may involve some physical characteristics of adhesion under conditions of flow: FMLPstimulated adherent PMNL may be more resistant to flow detachment than unstimulated PMNL attached to IL-1-stimulated HUVEC, even when CDl8 binding sites are blocked by TS1/18. On IL-1-and LPS-treated monolayers, unstimulated PMNL adhere and detach frequently, often remaining for only a minute or two. Consequently, there is considerable exchange between adherent and nonadherent populations of PMNL. Since FMLP-stimulated PMNL spread on the apical surface of the monolayer, the hydrodynamic drag forces acting on the stimulated PMNL are likely to be lower than on an unstimulated PMNL. A population of spread PMNL would experience on the average lower fluid drag forces compared with a population of nonspread PMNL attached to the monolayer under the same flow conditions. The lower fluid drag force combined with the larger cell contact area of a spread PMNL would be expected to lead to fewer detachments and an increase in the number of PMNL on the monolayer over time. By this means, FMLP could indirectly lead to an increase in PMNL adherence by stimulating morphologic changes that would not necessarily require adherence by a CD1 8-dependent mechanism, especially when a CD-18-independent mechanism (eg, ELAM-1) is present as a result of IL-1 stimulation.
PMNL rolling adhesions have been observed in tissue preparations by several investigators as a step in margination to the vessel wa11.5*33948 Shearing forces present due to fluid drag can induce a resultant force on the adherent PMNL that, depending on the strength of the adhesive interaction, could result in detachment, complete arrest, or when there is an intermediate level of adhesiveness, rolling in the direction of flow along the m~nolayer.~ Consistent with in vivo observations, the average rolling velocity on IL-1-treated HUVEC was proportional to the wall shear stress.48 At a wall shear stress of 0.5 dynes/cm2, approximately 60% of the PMNL on IL-1-treated HUVEC stopped rolling and a large proportion (greater than 40%) of these migrated through the monolayer. As discussed above, this migration appears to be a CD18-and ICAM-1 dependent event that likely involves some signal generated by IL-1-stimulated endothelium, perhaps an endothelial cell-derived chemotactic s t i m u l~s .~~.~' These observations also suggest that an exogenous chemotactic stimulus (FMLP) can markedly inhibit PMNL rolling on IL-1-treated HUVEC. The effect of FMLP highlights the difference between the adhesive mechanisms upregulated by cytokines such as IL-1, which modulate PMNL attachments and rolling adhesions, and chemotactic factors such as FMLP, which stimulate PMNL shape change, motility, and spreading.
Since shear forces are continuously acting on the PMNL and HUVEC monolayer from the time of initial contact to the formation of a stable adhesion, the flow chamber assay essentially simulates an adhesive interaction analogous to margination in vivo. The lack of inhibition of adherence at 2 dynes/cm2 with CD1 8-deficient PMNL and results of MoAbblocking experiments suggest that PMNL can successfully form attachments and rolling adhesions with the vessel wall (ie, marginate) when the endothelium has been activated by a cytokine such as IL-1, but apparently require CD18 to migrate into tissue. Experiments at varying flow conditions also demonstrate that CD 18-mediated adhesion of PMNL to HUVEC is a sensitive function of the shear stress. Under flow conditions, it appears possible to separate the adhesive interaction into a CDlS/ICAM-l-dependent component, which seems to operate at wall shear stresses up to 0.5 dynes/cm*; and a CDl I/ICAM-1-independent component that operates at wall shear stresses up to 3 dynes/cm2.
The incorporation of physiologic flow dynamics allows some aspects of leukocyte interactions with endothelial cells to be simulated in a more realistic fashion than is possible in a static assay. However, it is admittedly a very simplified model system and the constant wall shear stresses generated by steady flow reported in these experiments are not exact correlates of in vivo conditions. Nevertheless, the shear stress dependence of adhesion observed in these model vessel experiments suggest that local flow rates in the vasculature could play an important role in conjunction with the expression of cell surface adhesive glycoproteins in regulating the margination and initial attachment of leukocytes to the blood vessel wall.
